824
Views
76
CrossRef citations to date
0
Altmetric
Review Article

A comparison of rat chronic progressive nephropathy with human renal disease—implications for human risk assessment

, &
Pages 332-346 | Received 02 May 2008, Accepted 25 Jul 2008, Published online: 01 Apr 2009

References

  • Abrass, C. K. (2000). The nature of chronic progressive nephropathy in aging rats. Adv. Renal Replacement Ther. 7:4–10.
  • Abrass, C. K., Adcox, M. J., and Raugi, G. J. (1995). Aging-associated changes in renal extracellular matrix. Am. J. Pathol. 146:742–752.
  • Addis, T., Marmorston, J., Goodman, H. C., Sellers, L., and Smith, M. (1950). Effect of adrenalectomy on spontaneous and induced proteinuria in the rat. Proc. Soc. Exp. Biol. Med. 74:42–46.
  • Alt, J. M., Hackbarth, H., Deerberg, F., and Stolte, H. (1980). Proteinuria in rats in relation to age-dependent renal changes. Lab Animals 14:95–101.
  • Anver, M. R., Cohen, B. J., Lattuada, C. P., and Foster, S. J. (1982). Age-associated lesions in barrier-reared male Sprague–Dawley rats: A comparison between Hap: (SD) and Crl:COBS[R]CD[R](SD) stocks. Exp. Aging Res. 8:3–24.
  • Barthold, S. W. (1979). Chronic progressive nephropathy in aging rats. Toxicol. Pathol. 7:1–6.
  • Barthold, S. W. (1998). Chronic progressive nephropathy, rat. In: Monographs on pathology of laboratory animals. Urinary system (eds T. C. Jones, G. C. Hard, and U. Mohr, 2nd ed.). Springer–Verlag, Berlin, Germany, pp 228–233.
  • Baylis, C. (1994). Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J. Clin. Invest. 94:1823–1829.
  • Baylis, C., and Corman, B. (1998). The aging kidney: Insights from experimental studies. J. Am. Soc. Nephrol. 9:699–709.
  • Bell, R. H., Borjesson, B. A., Wolf, P. L., Fernadez-Cruz, L., Brimm, J. E., Lee, S., Sayers, H. J., and Orloff, M. J. (1984). Quantitative morphological studies of aging changes in the kidney of the Lewis rat. Renal Physiol. Basel 7:176–184.
  • Bell, G. M., Gordon, A. C. H., Lee, P., Doig, A., MacDonald, M. K., Thomson, D., Anderton, J. L., and Robson, J. S. (1985). Proliferative glomerulonephritis and exposure to organic solvents. Nephron 40:161–165.
  • Berg, B. N. (1965). Spontaneous nephrosis, with proteinuria, hyperglobulinemia, and hypercholesterolemia in the rat. Proc. Soc. Exp. Biol. Med. 119:417–420.
  • Bertani, T., Perico, N., Abbate, M., Battaglia, C., and Remuzzi, G. (1987). Renal injury induced by long-term administration of cyclosporin A to rats. Am. J. Pathol. 127:569–579.
  • Bertani, T., Zoja, C., Abbate, M., Rossini, M., and Remuzzi, G. (1989). Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content. Lab. Invest. 60:196–204.
  • Blair, J. T., Thomson, A. W., Whiting, P. H., Davidson, R. J. L., and Simpson, J. G. (1982). Toxicity of the immune suppressant cyclosporin A in the rat. J. Path. 139:163–178.
  • Boero, R., Pignataro, A., and Quarello, F. (2002). Salt intake and renal disease. J. Nephrol. 15:225–229.
  • Bolton, W. K. (1996). Goodpasture’s syndrome. Kidney Int. 50:1753–1766.
  • Boobis, A. R., Cohen, S. M., Dellarco, V., McGregor, D., Meek, M. E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36:781–792.
  • Borza, D. B., Neilson, E. G., and Hudson, B. G. (2003). Pathogenesis of Goodpasture’s syndrome: a molecular perspective. Semin. Nephrol. 23:522–531.
  • Bosmans, J. L. and Verpooten, G. A. (2007). Malignancy after kidney transplantation: Still a challenge. Kidney Int. 71:1197–1199.
  • Brenner, B. M. (1985). Nephron adaptation to renal injury or ablation. Am. J. Physiol. 249:F324–F337.
  • Busnach, G., Piselli, P., Arbustini, E., Baccarani, U., Burra, P., Carrieri, M. P., Citterio, F., De Juli, E., Bellelli, S., Pradier, C., Rezza, G., and Serraino, D. (2006). Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc. 38:3533–3535.
  • Chatterjee, B., Demyan, W. F., Song, C. S., Garg, B. D., and Roy, A. K. (1989). Loss of androgenic induction of a2u-globulin gene family in the liver of NIH Black rats. Endocrinology 125:1385–1388.
  • Cohen, S. M., Purtilo, D. T., and Ellwein, L. B. (1991). Pivotal role of increased cell proliferation in human carcinogenesis. Modern Pathol. 4:371–382.
  • Coleman, G. L., Barthold, S. W., Osbaldiston, G. W., Foster, S. J., and Jonas, A. (1977). Pathological changes during aging in barrier-reared Fischer 344 rats. J. Gerontol. 32:258–278.
  • Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., and Levey, A. S. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41:1–12.
  • Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., and Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047.
  • Cossu-Rocca, P., Eble, J. N., Zhang, S., Martignoni, G., Brunelli, M., and Cheng, L. (2006). Acquired cystic disease-associated renal tumors: An immunohistochemical and fluorescence in situ hybridization study. Modern Pathol. 19:780–787.
  • Couser, W. G. (1999). Glomerulonephritis. Lancet 353:1509–1515.
  • Couser, W. G. and Stillmant, M. M. (1975). Mesangial lesions and focal glomerular sclerosis in the aging rat. Lab. Invest. 33:491–501.
  • Cowden, E. A., Dobbie, J. W., Mountjoy, K., Ratcliffe, J. G., Richardson, B., and Kennedy, A. C. (1981). Prolactin status in chronic nephropathy in the rat. Nephron 27:84–88.
  • D’Agati, V. D., Jennette, J. C., and Silva, F. G. (2005). Non-neoplastic kidney diseases. Atlas of nontumor pathology. First series, Fascicle 4. American Registry of Pathology and Armed Forces Institute of Pathology, Washington, DC, pp. 457–480 and 643–665.
  • Dietrich, D. R., and Swenberg, J. M. (1991). The presence of a2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res. 51:3512–3521.
  • de Jong, P. E., Halbesma, N., and Gansevoort, R. T. (2006). Screening for early chronic kidney disease—What method fits best? Nephrol. Dial. Transplant 21:2358–2361.
  • Doublet, J., Peraldi, M., Gattegno, B., Thibault, P., and Sraer, J. D. (1997). Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J. Urol. 158:42–44.
  • Eddy, A. A. (2005). Progression in chronic kidney disease. Adv. Chronic Kidney Dis. 12:353–365.
  • Ekart, R., and Hojs, R. (2006). Acquired cystic kidney disease and arterial hypertension in hemodialysis patients. Wien Klin. Wochenschr. 118:17–22.
  • Elema, J. D., and Arends, A. (1975). Focal and segmental glomerular hyalinosis and sclerosis in the rat. Lab. Invest. 33:554–561.
  • Everitt, A. V., and Duvall, L. K. (1965). Delayed onset of proteinuria in aging hypophysectomized rats. Nature 205:1016.
  • Everitt, A. V., Porter, B. D., and Wyndham, J. R. (1982). Effects of caloric intake and dietary composition on the development of proteinuria, age-associated renal disease and longevity in the male rat. Gerontology 28:168–175.
  • Everitt, A. V., Wyndham, J. R., and Barnard, D. J. (1983). The anti-aging action of hypophysectomy in hypothalamic obese rats: effects on collagen aging, age-associated proteinuria development and renal histopathology. Mech. Ageing Dev. 22:233–251.
  • Foley, R. N., and Collins, A. J. (2007). End-stage renal disease in the United States: An update from the United States Renal Data System. J. Am. Soc. Nephrol. 18:2644–2648.
  • Foley, W. A., Jones, D. C. L., Osborn, G. K., and Kimeldorf, D. J. (1964). A renal lesion associated with diuresis in the aging Sprague–Dawley rat. Lab. Invest. 13:439–450.
  • Frankel, A., Brown, E., and Wingfield, D. (2005). Management of chronic kidney disease. Br. Med. J. 330:1039–1040.
  • Frocht, A., and Fillit, H. (1984). Renal disease in the geriatric patient. J. Am. Geriatr. Soc. 32:28–43.
  • Galla, J. H. (1995). IgA nephropathy. Kidney Int. 47:377–387.
  • Gilbert, R. E., and Cooper, M. E. (1999). The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int. 56:1627–1637.
  • Goldstein, R. S., Tarloff, J. B., and Hook, J. B. (1988). Age-related nephropathy in laboratory rats. FASEB J. 2:2241–2251.
  • Gordon, R. D., Laragh, J. H., and Funder, J. W. (2005). Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol. Metab. 16:108–113.
  • Gough, A. W., Reindell, J. F., McGuire, E. J., and de la Iglesia, F. A. (1993). Histopathologic findings in rodents treated two years with the angiotensin converting enzyme inhibitor, quinapril hydrochloride [abstract]. Toxicol. Pathol. 21:594.
  • Goya, R. G., Castelletto, L., and Sosa, Y. E. (1991). Plasma levels of growth hormone correlate with the severity of pathologic changes in the renal structure of aging rats. Lab. Invest. 64:29–34.
  • Gray, J. E. (1977). Chronic progressive nephrosis in the albino rat. Crit. Rev. Toxicol. 5:115–144.
  • Gray, J. E., Van Zwieten, M. J., and Hollander, C. F. (1982). Early light microscopic changes of chronic progressive nephrosis in several strains of aging laboratory rats. J. Gerontol. 37:142–150.
  • Gray, J., Weaver, R., and Connor, N. (1974a). Observations on the kidneys and urine of the wild Norway rat, Rattus norvegicus. Vet. Pathol. 11:144–152.
  • Gray, J. E., Weaver, R. N., and Purmalis, A. (1974b). Ultrastructural observations of chronic progressive nephrosis in the Sprague–Dawley rat. Vet. Pathol. 11:153–164.
  • Greaves, P. (2007). Histopathology of preclinical toxicity studies (3rd ed.). Elsevier, Amsterdam, pp 570–660.
  • Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brda, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelic, M., and Jelakovic, B. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U S A 104:12129–12134.
  • Gutierrez-Dalmau, A. and Campistol, J. M. (2007). Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67:1167–1198.
  • Habermann, R., Williams, F., and Thorp, W. (1954). Common infections and disease conditions observed in wild Norway rats kept under simulated natural conditions. Am. J. Vet. Res. 15:152–156.
  • Hallan, S., Coresh, J., Astor, B. C., Asberg, A., Powe, N. R., Romundstad, S., Hallan, H. A., Lydersen, S., and Holmen, J. (2006). International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J. Am. Soc. Nephrol. 17:2275–2284.
  • Hard, G. C. (1998). Mechanisms of chemically induced renal carcinogenesis in the laboratory rodent. Toxicol. Pathol. 26:104–112.
  • Hard, G. C. (1999). Comparative kidney carcinogenesis in laboratory rodents and humans. In: Carcinogenicity. Testing, predicting, and interpreting chemical effects (ed. K. T. Kitchen). Marcel Dekker, New York, pp. 439–466.
  • Hard, G. C. (2002). Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk. Toxicol. Sci. 69:30–41.
  • Hard, G. C., Alden, C. L., Stula, E. F., and Trump, B. F. (1995). Proliferative lesions of the kidney in rats. In: Guides for toxicologic pathology. STP/ARP/AFIP, Washington, DC, pp. 1–19.
  • Hard, G. C., and Khan, K. N. (2004). A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol. Pathol. 32:171–180.
  • Hard, G. C., Rodgers, I. S., Baetcke, K. P., Richards, W. L., McGaughy, R. E., and Valcovic, L. R. (1993). Hazard evaluation of chemicals that cause accumulation of a2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ. Health Perspect. 99:313–349.
  • Hard, G. C., and Seely, J. C. (2005). Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN). Toxicol. Pathol. 33:641–649.
  • Hard, G. C., and Seely, J. C. (2006). Histological investigation of diagnostically challenging tubule profiles in advanced chronic progressive nephropathy (CPN) in the Fischer 344 rat. Toxicol. Pathol. 34:941–948.
  • Hard, G. C., Seely, J. C., Betz, L. J., and Hayashi, S. (2007). Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin. Food Chem. Toxicol. 45:600–608.
  • Hard, G. C., Whysner, J., English, J. C., Zang, E., and Williams, G. M. (1997). Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy. Toxicol. Pathol. 25:132–143.
  • Hartmann, A. E. (1994). Nitrogen metabolites and renal function. In: Clinical laboratory medicine (ed. K. D. McClatchey). Williams and Wilkins, Philadelphia, PA, pp. 371–385.
  • Hayashida, M., Yu, B. P., Masoro, E. J., Iwasaki, K., and Ikeda, T. (1986). An electron microscopic examination of age-related changes in the rat kidney: The influence of diet. Exp. Gerontol. 21:535–553.
  • Haysom, L., Williams, R., Hodson, E., Roy, L. P., Lyle, D., and Craig, J. C. (2007). Early chronic kidney disease in aboriginal and non-aboriginal Australian children: Remoteness, socioeconomic disadvantage or race? Kidney Int. 71:787–794.
  • Heinz-Peer, G., Schoder, M., Rand, T., Mayer, G., and Mostbeck, G. H. (1995). Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: A prospective US study. Radiology 195:667–671.
  • Hirokawa, K. (1975). Characterization of age-associated kidney disease in Wistar rats. Mech. Ageing Dev. 4:301–316.
  • Horbach, G. J. M. J., Durham, S. K., Yap, S. H., and van Bezooijen, C. F. A. (1988). Albumin elimination in female WAG/Rij rats with age: A longitudinal study. Mech. Ageing Develop. 43:137–152.
  • Hranjec, T., Kovac, A., Kos, J., Mao, W., Chen, J. J., Grollman, A. P., and Jelakovic, B. (2005). Endemic nephropathy: The case for chronic poisoning by Aristolochia. Croat. Med. J. 46:116–125.
  • Hughson, M. D., Buchwald, D., and Fox, M. (1986). Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch. Pathol. Lab. Med. 110:592–601.
  • Ishikawa, I., Saito, Y., Shikura, N., Kitada, H., Shinoda, A., and Suzuki, S. (1990). Ten-year prospective study on the development of renal cell carcinoma in dialysis patients. Am. J. Kid. Dis. 16: 452–458.
  • Iwasaki, K., Gleiser, C. A., Masoro, E. J., McMahan, C. A., Seo, E. J., and Yu, B. P. (1988a). The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J. Gerontol. 43:B5–B12.
  • Iwasaki, K., Gleiser, C. A., Masoro, E. J., McMahan, C. A., Seo, E. J., and Yu, B. P. (1988b). Influence of the restriction of individual dietary components on longevity and age-related disease of Fischer rats: The fat component and the mineral component. J. Gerontol. 43:B13–B21.
  • Johnson, D. W. (2006). Dietary protein restriction as a treatment for slowing chronic kidney disease progression: The case against. Nephrology 11:58–62.
  • Jones, C. A., Krolewski, A. S., Rogus, J., Xue, J. L., Collins, A., and Warram, J. H. (2005). Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int. 67:1684.
  • Keenan, K. P., Coleman, J. B., McCoy, C. L., Hoe, C. M., Soper, K. A., and Laroque, P. (2000). Chronic nephropathy in ad libitum overfed Sprague–Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth. Toxicol. Pathol. 28:788–798.
  • Kleinknecht, C., Laouari, D., Hinglais, N., Habib, R., Dodu, C., Lacour, B., and Broyer, M. (1986). Role of amount and nature of carbohydrates in the course of experimental renal failure. Kidney Int. 30:687–693.
  • Kojima, Y., Takahara, S., Miyake, O., Nonomura, N., Morimoto, A., and Mori, H. (2006). Renal cell carcinoma in dialysis patients: A single center experience. Int. J. Urol. 13:1045–1048.
  • Konishi, N., and Ward, J. M. (1989). Increased levels of DNA synthesis in hyperplastic renal tubules of aging nephropathy in female F344/NCr rats. Vet. Pathol. 26:6–10.
  • Lassila, M., Santisteban, J., Finckenberg, P., Salmenpera, P., Riutta, A., Moilanen, E., Virtanen, I., Vapaatalo, H., and Nurminen, M. L. (2001). Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. J. Physiol. Pharmacol. 52:21–38.
  • Levey, A. S., Greene, T., Sarnak, M. J., Wang, X., Beck, G. J., Kusek, J. W., Collins, A. J., and Kopple, J. D. (2006). Effect of dietary protein restriction on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am. J. Kid. Dis. 48:879–888.
  • Lock, E. A. (1999). Responses of the kidney to toxic compounds. In: General and applied toxicology, Vol 2, (eds B. Ballantyne, T. C. Marrs, and T. Syversen, 2nd ed.). Macmillan Reference Ltd, London, pp. 675–700.
  • Lock, E. A., and Hard, G. C. (2004). Chemically-induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 34:211–299.
  • Magro, A. M., and Rudofsky, U. H. (1982). Plasma rennin activity decrease preceded focal glomerular sclerosis in aging rats. Nephron 31:245–253.
  • Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolfe, R. A., Jones, E., Disney, A. P., Briggs, D., McCredie, M., and Boyle, P. (2000). Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am. J. Kid. Dis. 35:157–165.
  • Mally, A., Hard, G. C., and Dekant, W. (2007). Ochratoxin A as a potential factor in endemic nephropathy: Lessons from toxicity studies in rats. Food Chem. Toxicol. 45:2254–2260.
  • Mandayam, S., and Mitch, W. E. (2006). Dietary protein restriction benefits patients with chronic kidney disease. Nephrology 11:53–57.
  • Manninen, A. H. (2005). High-protein diets are not hazardous for healthy kidneys. Nephrol. Dial. Transplant 20:657–658.
  • Martin, J. E., and Sheaff, M. T. (2007). Renal ageing. J. Pathol. 211:198–205.
  • Masoro, E. J., and Yu, B. P. (1989). Diet and nephropathy. Lab. Invest. 60:165–167.
  • Masoro, E. J., Iwasaki, K., Gleiser, C. A., McMahan, C. A., Seo, E. J., and Yu, B. P. (1989). Dietary modulation of the progression of nephropathy inaging rats: An evaluation of the importance of protein. Am. J. Clin. Nutr. 49:1217–1227.
  • Matson, M. A., and Cohen, E. P. (1990). Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine 69:217–226.
  • McCoy, G. W. (1908). Pathological conditions found in rats: observations based on 50000 rats in the laboratories of the Public Health and Marine Hospital. Public Health Rep. US Public Health Marine Hosp. Service 23:1365–1371.
  • McPherson, R. A., Ben-Ezra, J., and Zhao, S. (2007). Basic examination of urine. In: Henry’s clinical diagnosis and management by laboratory methods (eds R. A. McPherson and M. R. Pincus, 21st ed.). Saunders–Elsevier, Philadelphia, pp. 394–425.
  • Meek, M. E., Bucher, J. R., Cohen, S. M., Dellarco, V., Hill, R. N., Lehman-McKeeman, L. D., Longfellow, D. G., Pastor, T., Seed, J., and Patton, D. E. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33:591–653.
  • Michielsen, P. (2007). In memoriam “analgesic nephropathy” (circa 1972–2006). Nephrol. Dial. Transplant 22:999–1001.
  • Mihatsch, M. J., Khanlari, B., and Brunner, F. P. (2006). Obituary to analgesic nephropathy—An autopsy study. Nephrol. Dial. Transplant 21:3139–3145.
  • Montgomery, C. A., and Seely, J. C. (1990). Kidney. In: Pathology of the Fischer rat. Reference and atlas (eds G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, and W. F. MacKenzie). Academic Press, San Diego, CA, pp. 127–153.
  • Moudouni, S. M., Lakmichi, A., Tligui, M., Rafii, A., Tchala, K., Haab F., Gattegno, B., Thibault, P., and Doublet, J. D. (2006). Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int. 98:298–302.
  • Murty, C. V., Sarkar, F. H., Mancini, M. A., and Roy, A. K. (1987). Sex-independent synthesis of alpha 2u-globulin and its messenger ribonucleic acid in the rat preputial gland: Biochemical and immunocytochemical analyses. Endocrinology 121:1000–1005.
  • Nakatsuji, S., Yamate, J., and Sakuma, S. (1998). Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats. Vet. Pathol. 35:352–360.
  • Neuhaus, O. W. and Flory, W. (1978). Age-dependent changes in the excretion of urinary proteins by the rat. Nephron 22:570–576.
  • National Toxicology Program (NTP). (2004a). Chemicals associated with site-specific tumor induction in kidney tubular cell. Accessed from http://ntp-server.niehs.nih.gov/htdocs/sites/psite_cnt.html on 18 May 2004.
  • National Toxicology Program (NTP). (2004b). Toxicology and carcinogenesis studies of benzophenone (Cas no. 119-61-9) in F344/N rats and B6C3F1 mice (feed studies). NTP Technical Report 533, National Institutes of Health Publication 06-4469.
  • National Toxicology Program (NTP). (2007). Toxicology and carcinogenesis studies of methyl isobutyl ketone (Cas no. 108-10-1) in F344/N rats and B6C3F1 mice (inhalation studies). NTP Technical Report 538, National Institutes of Health Publication 07-4476.
  • Ordonez, N. G., and Rosai, J. (2004). Urinary tract. In: Rosai and Ackerman’s surgical pathology (ed. J. Rosai, 9th ed.). Mosby, New York, pp. 1164–1240.
  • Pai, P., Stevenson, A., Mason, H., and Bell, G. M. (1998). Occupational hydrocarbon exposure and nephrotoxicity: A cohort study and literature review. Postgrad. Med. J. 74:225–228.
  • Palm, M. (1998). The incidence of chronic progressive nephrosis in young Sprague–Dawley rats from two different breeders. Lab. Animals 32:477–482.
  • Pashko, L. L., Fairman, D. K., and Schwartz, A. G. (1986). Inhibition of proteinuria development in aging Sprague–Dawley rats and C57BL/6 mice by long-term treatment with dehydroepiandrosterone. J. Gerontol. 41:433–438.
  • Peleg, I., Greenfield, Z., Cooperman, H., and Shoshan, S. (1993). Type I and Type III collagen mRNA levels in kidney regions of old and young rats. Matrix 13:281–287.
  • Peterson, R. O. (1994). The urinary tract and male reproductive system. In: Pathology (eds E. Rubin and J. L. Farber, 2nd ed.). JB Lippincott, Philadelphia, pp. 866–907.
  • Polrogt, L., McCollum, E., and Simmonds, N. (1923). Production of kidney lesions in rats by diets defective only in that they contained excessive amounts of protein. Bull. Johns Hopkins Hosp. 34:168–172.
  • Poortmans, J. R., and Dellalieux, O. (2000). Do regular high-protein diets have potential health risks on function in athletes? Int. J. Sports Nutr. 10:29–38.
  • Rao, G. N. (1996). New diet (NTP 2000) for rats in the National Toxicology Program toxicity and carcinogenicity studies. Fundam. Appl. Toxicol. 32:102–108.
  • Rao, G. N., Edmondson, J., and Elwell, M. R. (1993). Influence of dietary protein concentration on severity of nephropathy in Fischer-344 (F-344/N) rats. Toxicol. Pathol. 21:353–361.
  • Rao, G. N., Morris, R. W., and Seely, J. C. (2001). Beneficial effects of NTP-2000 diet on growth, survival, and kidney and heart diseases of Fischer F344 rats in chronic studies. Toxicol. Sci. 63:245–255.
  • Razzaque, M. S., Shimokawa, I., Nazneen, A., Higami, Y., and Taguchi, T. (1998). Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47. Cell Tissue Res. 293:471–478.
  • Richardson, A., Butler, J. A., Rutherford, M. S., Semsei, I., Gu, M. Z., Fernandes, G., and Chiang, W. H. (1987). Effect of age and dietary restriction on the expression of a2u-globulin. J. Biol. Chem. 262:12821–12825.
  • Richardson, B., and Luginbuhl, H. (1976). The role of prolactin in the development of chronic progressive nephropathy in the rat. Virchow Arch. A. Pathol. Anat. Histol. 370:13–19.
  • Richardson, B. P., Turkalj, I., and Flückiger, E. (1984). Bromocriptine. In: Safety testing of new drugs: Laboratory predictions and clinical performance (eds D. R. Laurence, A. E. M. McClean, and M. Weatherall). Academic Press, London, pp. 19–63.
  • Roy, A. K., Nath, T. S., Motwani, N. M., and Chatterjee, B. (1983). Age-dependent regulation of the polymorphic forms of a2u-globulin. J. Biol. Chem. 258:10123–10127.
  • Rutkowski, B., Tylicki, L., Manitius, J., and Lysiak-Szydlowska, W. (1999). Hypertensive nephropathy—An increasing problem. Mineral Electrolyte Metab. 25:65–68.
  • Salatka, K., Kresge, D., Harris, L., Edelstein, D., and Ove, P. (1971). Rat serum protein changes with age. Exp. Gerontol. 6:25–36.
  • Sanders, P. W. (2007). Effect of salt intake on progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 15:54–60.
  • Saxton, J. A., and Kimball, G. C. (1941). Relation of nephrosis and other diseases of albino rats to age and to modifications of diet. Arch. Pathol. 32:951–965.
  • Schwartz, M. M. (2007). The pathology of lupus nephritis. Semin. Nephrol. 27:22–34.
  • Seely, J. C., Haseman, J. K., Nyska, A., Wolf, D. C., Everitt, J. I., and Hailey, J. R. (2002). The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats. Toxicol. Pathol. 30:681–686.
  • Shaldon, S., and Vienken, J. (2008). The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients. Nephrol. Dial. Transplant. 23:2118–2120.
  • Short, B. G., and Goldstein, R. S. (1992). Nonneoplastic lesions in the kidney. In: Pathobiology of the aging rat, Volume 1 (eds U. Mohr, D. L. Dungworth, and C. C. Capen). ILSI Press, Washington, DC, pp. 211–225.
  • Short, B. G., Burnett, V. L., and Swenberg, J. A. (1989). Elevated proliferation of proximal tubule cells and localization of accumulated a2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane. Toxicol. Appl. Pharmacol. 101:414–431.
  • Silva, F. G., and Hogg, R. J. (1988). Glomerular lesions associated with the acute nephritic syndrome and hematuria. Semin. Diagn. Pathol. 5:4–38.
  • Snell, K. C. (1967). Renal disease of the rat. In: Pathology of rats and mice (eds E. Cotchin and F. J. C. Roe). Blackwell Scientific Publications, Oxford, UK, pp. 105–147.
  • Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J. M., and Younes, M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34:146–152.
  • Starklint, H., Hansen, H. V., Kemp, M., Leyssac, P. P., Kemp, E., and Dieperink, H. (1994). Long-term cyclosporin A nephrotoxicity in the rat. APMIS 102:347–355.
  • Stefanovic, V., and Polenakovic, M. H. (1991). Kidney disease beyond the Balkans? Am. J. Nephrol. 11:1–11.
  • Stengel, B., and Couchoud, C. (2006). Chronic kidney disease prevalence and treated end-stage renal disease incidence: A complex relationship. J. Am. Soc. Nephrol. 17:2094–2096.
  • Stevens, L. A., Coresh, J., Greene, T., and Levey, A. S. (2006). Assessing kidney function: measured and estimated glomerular filtration rate. N. Engl. J. Med. 354:2473–2483.
  • Suzuki, H., Takenaka, T., Kanno, Y., Ohno, Y., and Saruta, T. (2007). Sodium and kidney disease. Contrib. Nephrol. 155:90–101.
  • Sworn, M. J., and Fox, M. (1974). Renal age changes in the rat compared with human renal senescence. Investig. Urol. 12:140–145.
  • Tauchi, H., Yoshioka, T., and Kobayashi, H. (1971). Age changes in the human kidney of different races. Gerontologia 16:368–380.
  • Tanaka, A., Kyokuwa, M., Mori, T., and Kawashima, S. (1995). Acceleration of renal dysfunction with ageing by the use of androgen in Wistar/Tw rats. In Vivo 9:495–502.
  • Taylor, S. A., and Price, R. G. (1982). Age-related changes in rat glomerular basement membrane. Int. J. Biochem. 14:201–206.
  • Thudium, D., Adams, D., Sellers, T., Rehm, S., Ennulat, D., and Schwartz, L. (2001). Urinary albumin as a sensitive marker for nephropathy in aged male rats [abstract]. Vet. Pathol. 38:571.
  • Tickoo, S. K., dePeralta-Venturina, M. N., Harik, L. R., Worcester, H. D., Salama, M. E., Young, A. N., Moch, H., and Amin, M. B. (2006). Spectrum of epithelial neoplasms in end-stage renal disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 30:141–153.
  • Toto, R. D. (2001). Hypertension and the failing kidney. Curr. Opin. Nephrol. Hypertens. 10:165–166.
  • Travlos, G. S., Betz, L., and Hard, G. C. (2007). Influence of diet or route of exposure on chronic progressive nephropathy, kidney weight, blood urea nitrogen and creatinine concentrations in 13-week toxicity studies for control F344/N male rats [abstract]. Toxicol. Pathol. 35:190–191.
  • Truong, L. D., Krishnan, B., Cao, J. T., Barrios, R., and Suki, W. N. (1995). Renal neoplasm in acquired cystic kidney disease. Am. J. Kidney Dis. 26:1–12.
  • Tuttle, K. R. (2001). Ischemic nephropathy. Curr. Opin. Nephrol. Hypertens. 10:167–173.
  • Uwagawa, S., Saito, K., Nakayama, A., Umihira, M., and Okuno, Y. (1990). Comparison of hyaline droplets in rats with chronic progressive nephropathy and chemical-induced a2u-globulin nephropathy. J. Toxicol. Pathol. 5:195–203.
  • Vajdic, C. M., McDonald, S. P., McCredie, M. R. E., Leeuwen, M. T., Stewart, J. H., Law, M., Chapman, J. R., Webster, A. C., Kaldor, J. M., and Grulich, A. E. (2006). Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831.
  • Vandoren, G., Mertens, B., Heyns, W., Van Baelen, H., Rombauts, W., and Verhoeven, G. (1983). Different forms of a2u-globulin in male and female rat urine. Eur. J. Biochem. 134:175–181.
  • Van Ypersele de Strihou, C., and Vanherweghem, J. L. (1995). The tragic paradigm of Chinese herbs nephropathy. Nephrol. Dial. Transplant 10:157–160.
  • Ward, J. M., and Reznik-Schüller, H. (1980). Morphological and histochemical charcteristics of pigments in aging F344 rats. Vet. Pathol. 17:678–685.
  • Weir, M. R., and Fink, J. C. (2005). Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am. J. Kid. Dis. 45:176–188.
  • Wilens, S. L., and Sproul, E. E. (1938). Spontaneous cardio-vascular disease in the rat. II. Lesions of the vascular system. Am. J. Path. 14:201–216.
  • Wimmer, C. D., Rentsch, M., Crispin, A., Illner, W. D., Arbogast, H., Graeb, C., Jauch, K. W., and Guba, M. (2007). The janus face of immunosuppression—De novo malignancy after renal transplantation: The experience of the Transplantation Center Munich. Kidney Int. 71:1271–1278.
  • Wolf, D. C., and Hard, G. C. (1996). Pathology of the kidneys. In: Pathology of the aging mouse, Volume 1. (eds U. Mohr, D. L. Dungworth, C. C. Capen, W. W. Carlton, J. P. Sundberg, and J. M. Ward). ILSI Press, Washington DC, pp. 331–344.
  • Wolf, D. C., and Mann, P. C. (2005). Confounders in interpreting pathology for safety and risk assessment. Toxicol. Appl. Pharmacol. 202:302–308.
  • Wolk, A., Gridley, G., Niwa, S., Lindblad, P., McCredie, M., Mellemgaard, A., Mandel, J., Wahrendorf, J., McLaughlin, J. K., and Adami, H. O. (1996). International renal-cell cancer study. VII. Role of diet. Int. J. Cancer 65:67–73.
  • Yu, B. P., Masoro, E. J., Murata, I., Bertrand, H. A., and Lynd, F. T. (1982). Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: Longevity, growth, lean body mass and disease. J. Gerontol. 37:130–141.
  • Zawada, E. T., Alavi, F. K., Santella, R. N., and Maddox, D. A. (1997). Influence of dietary macronutrients on glomerular senescence. Curr. Nephrol. 20:1–47.
  • Zeisberg, M., Strutz, F., and Muller, G. A. (2001). Renal fibrosis: An update. Curr. Opin. Nephrol. Hypertens. 10:315–320.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.